Abstract:As a typical case of the optimal planning for the provision of restricted medical resources, widespread vaccination is considered an effective and sustainable way to prevent and control large-scale novel coronavirus disease 2019 (COVID-19) outbreaks. However, an initial supply shortage of vaccines is inevitable because of the narrow production and logistical capacity. This work focuses on the multi-type vaccine resource allocation problem in a two-dose vaccination campaign under limited supply. To address this issue, we extended an age-stratified susceptible, exposed, infectious, and recovered (SEIR) epidemiological model to incorporate a two-dose vaccination campaign involving multiple vaccine types to fully characterize the various stages of infection and vaccination. Afterward, we integrated the proposed epidemiological model into a nonlinear programming (NLP) model to determine the optimal allocation strategy under supply capacity and vaccine hesitancy constraints with the goal of minimizing the cumulative number of deaths due to the pandemic over the entire planning horizon. A case study based on real-world data from the initial mass vaccination campaign against COVID-19 in the Midlands, England, was taken to validate the applicability of our model. Then, we performed a comparative study to demonstrate the performance of the proposed method and conducted an extensive sensitivity analysis on critical model parameters. Our results indicate that prioritizing the allocation of vaccines to elderly persons is an effective strategy for reducing COVID-19-related fatalities. Furthermore, we found that vaccination alone will not be sufficient for epidemic control in the short term, and appropriate non-pharmacological interventions are still important for effective viral containment during the initial vaccine rollout. The results also showed that the relative efficacy of the first dose is a vital factor affecting the optimal interval between doses. It is always best to complete the two-dose vaccination schedule as soon as possible when the relative efficacy of the first dose is low. Conversely, delaying the second dose of a vaccine as long as possible to increase the proportion of the population vaccinated with a single dose tends to be more favorable when the relative efficacy of the first dose is high. Finally, our proposed model is general and easily extendable to the study of other infectious disease outbreaks and provides important implications for public health authorities seeking to develop effective vaccine allocation strategies for tackling possible future pandemics.

Optimal planning of the COVID-19 vaccine supply chain

An optimization framework for COVID-19 vaccine allocation and inventory management: A case study

Supply chain planning of vaccine and pharmaceutical clusters under uncertainty: The case of COVID-19

A decision support framework for optimal vaccine distribution across a multi-tier cold chain network

Designing an optimization model for the vaccine supply chain during the COVID-19 pandemic

Optimizing Two-Dose Vaccine Resource Allocation to Combat a Pandemic in the Context of Limited Supply: the Case of COVID-19.

Optimizing the COVID-19 cold chain vaccine distribution network with medical waste management: A robust optimization approach

Optimizing Vaccine Allocation Strategies in Pandemic Outbreaks: An Optimal Control Approach

A multi-echelon dynamic cold chain for managing vaccine distribution

Optimization modeling for pandemic vaccine supply chain management: A review and future research opportunities

An equitable and accessible vaccine supply chain network in the epidemic outbreak of COVID-19 under uncertainty

Optimal Allocation of Multi-Type Vaccines in a Two-Dose Vaccination Campaign for Epidemic Control: A Case Study of COVID-19

Optimizing Resource Allocation for COVID-19 Vaccination Planning within Long-Term Care Facilities: A Refined Multilevel Linear Programming Approach

Protect or prevent? A practicable framework for the dilemmas of COVID-19 vaccine prioritization

An integrated blockchain-enabled multi-channel vaccine supply chain network under hybrid uncertainties

A bi-objective optimization model to plan vaccination campaigns

Where to locate COVID-19 mass vaccination facilities?

COVID-19 Agent-Based Model with Multi-objective Optimization for Vaccine Distribution

A Robust Optimization Approach to a Real Humanitarian Cold Supply Chain Planning on the COVID-19 crisis

Vaccine network design to maximize immunization coverage

Dynamic Optimization of COVID-19 Vaccine Prioritization in the Context of Limited Supply